To RA patients like myself, drugs like Enbrel can feel like a miracle. Yes, we don’t want to rely on drugs, and, yes, there are side effects, and, sure, there are nasty warning labels. But the trade-off is life less limited by RA. Hope for a future that doesn’t include disability.
But that happily ever after is not the full story. Around 15-20% of Rheumatoid Arthritis patients have exhausted all the treatment options. The medications either result in too many side effects or become ineffective. For these patients, I imagine it feels like there’s not a lot of hope left.
A new drug just went through Phase 3 clinical trials that might offer these patients hope. Read more about it here.
My RAD Life 
#1 by Carla Kienast on April 8, 2016 - 6:51 pm
One of the great things about having this terrible condition today is that there are wonderful drugs in the pipeline. I have “failed” on nearly all the drugs, including the other JAK inhibitor, Xeljanz. It’s nice to know there is something waiting in the wings when I “fail” on my current treatment … Thanks for bringing this information to the forefront.
#2 by My RAD Life on April 11, 2016 - 7:12 pm
Carla, I’m so glad you found this info useful! I’ll keep posting these articles as I find them. It is truly fortunate that we’re living in a time when new treatments are consistently being approved.